Nov 6 (Reuters)- Wakamoto Pharmaceutical Co Ltd PARENT-ONLY FINANCIAL HIGHLIGHTS (in billions of yen unless specified) 6 months ended 6 months ended Year to Sep 30, 2025 Sep 30, 2024 Mar 31, 2026 LATEST YEAR-AGO LATEST RESULTS RESULTS FORECAST Sales 4.38 3.81 10.00 (+14.9 pct) (+5.3 pct) (+28.4 pct) Operating loss 195 mln loss 276 mln 200 mln Recurring loss 175 mln loss 256 mln 250 mln Net loss 134 mln loss 141 mln 200 mln (+210.4 pct) EPS loss 3.86 yen loss 4.08 yen 5.76 yen Ann Div 3.00 yen 3.00 yen -Q2 div NIL NIL -Q4 div 3.00 yen 3.00 yen NOTE - Wakamoto Pharmaceutical Co Ltd. To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4512.T